Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3525 Del Mar Heights Rd
#1888
San Diego, CA 92130Phone+1 858-215-2707
Summary
Education & Training
- Johns Hopkins UniversityResidency, Ophthalmology, 1996 - 1999
- HCA HealthONE /Presbyterian-St Luke’s Medical CenterInternship, Transitional Year, 1995 - 1996
- Harvard Medical SchoolClass of 1995
Certifications & Licensure
- CA State Medical License 2008 - 2024
- UT State Medical License 2002 - 2010
- MD State Medical License 1999 - 2009
- OH State Medical License 2000 - 2007
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Elected fellow American Institute for Medical and Bioengineering, 2016
- Elected fellow AAAS, 2010
- Elected fellow Association of American Physicians, 2010
- Join now to see all
Clinical Trials
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Start of enrollment: 2010 Feb 01
- Seven Year Update of Macular Degeneration Patients Start of enrollment: 2010 Dec 01
- Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 15 citationsA family with X-linked optic atrophy linked to the OPA2 locus Xp11.4-Xp11.2.Bradley J. Katz, Yu Zhao, Judith E. A. Warner, Zongzhong Tong, Zhenglin Yang
American Journal of Medical Genetics. Part A. 2006-10-15 - 1026 citationsA large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variantsLars G. Fritsche, Wilmar Igl, Jessica N. Cooke Bailey, Felix Grassmann, Sebanti Sengupta
Nature Genetics. 2016-02-01 - 296 citationsRANIBIZUMAB FOR PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: SUBGROUP ANALYSIS OF FIRST-YEAR ANCHOR RESULTSPeter K. Kaiser, David M. Brown, Kang Zhang, Henry L. Hudson, Frank G. Holz
American Journal of Ophthalmology. 2007-12-01
Press Mentions
- Dr. Kang Zhang and Team Demonstrate Promising Gene Therapy Treatment for Retinitis PigmentosaNovember 6th, 2019
- India- Dr. Kang Zhang and Team Demonstrate Landmark Artificial Intelligence Diagnoses of Pediatric AilmentsJuly 8th, 2019
- The (AI) Doctor Will See You Now: Study Finds Artificial Intelligence Diagnoses Flu, Gastroenteritis and Meningitis in Children More Accurately Than MedicsFebruary 11th, 2019
- Join now to see all
External Links
- Personal Websitehttps://www.kangzhangmd.com
- Twitterhttps://twitter.com/kangzhangmd
- Instagramhttps://www.instagram.com/kangzhangmdphd/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: